Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2025-12-25 @ 4:35 PM
NCT ID: NCT01995357
Description: None
Frequency Threshold: 0
Time Frame: Test A + Training Test A: Pooled data of Test A during part 1 and 2 of the study. Test B + Training Test B: Pooled data of Test B during part 1 and 2 of the study. Standard Care: Data from part 1 of the study only. No Adverse Events on SenSura.
Study: NCT01995357
Study Brief: The Influence of Baseplate Adhesive on the Degree of Leakage
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Test A + Training Test A Test Product A was used both during part one of the study (Test A) and part two (Training Test A) hence adverse events are reported collectively for Test Product A. Consequently, Test Product A is used for two periods compared to Standard care which has been used for only one. None None 0 22 8 22 View
Test B + Training Test B Test Product B was used both during part one of the study (Test B) and part two (Training Test B) hence adverse events are reported collectively for Test Product B. Consequently, Test Product B is used for two periods compared to Standard care which has been used for only one. None None 0 22 9 22 View
Standard Care Standard care was used only during part one of the study. i.e. for one period only. None None 0 22 3 22 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Cold or influenza SYSTEMATIC_ASSESSMENT Infections and infestations None View
Planned operation, non-study related SYSTEMATIC_ASSESSMENT Eye disorders None View
Herpes Zoster SYSTEMATIC_ASSESSMENT Infections and infestations None View
Diarrhea or constipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Peristomal skin irritation/broken skin/stomal bleeding SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Pain, leg SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View